Fluoguide AS

Research Fluoguide AS (FLUO) on Bullrun: market cap SEK 549.34M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerFLUO
ExchangeST
CountryDenmark
SectorHealthcare
IndustryBiotechnology
CurrencySEK
Market capSEK 549.34M
Financial periodQ1 2026
RevenueDKK 0
Net income-DKK 11.79M
Free cash flow-DKK 15.20M

Valuation Snapshot

latest market cap is SEK 549.34M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	DKK 0	-DKK 39.46M	-DKK 36.96M	n/a	-2.79	DKK 48.79M	DKK 28.29M	DKK 54.53M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-09-28	SEK 549.34M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Fluoguide AS

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment of brain cancer through photothermal and photodynamic therapies.

Related stock research

Denmark stocks Denmark Healthcare stocks A-Z stock index

Other Healthcare stocks

ALK-Abelló A/S (ALK-B) Ascendis Pharma A/S (ASND) Bavarian Nordic (BAVA.CO) Evaxion Biotech A/S (EVAX) Galecto Inc (GLTO) Genmab (GMAB) Gubra A/S (GUBRA) Initiator Pharma A/S (INIT) IO Biotech Inc (IOBT) Pharma Equity Group (PEG.CO) Saniona AB (SANION) STRAP (STRAP)

Frequently asked questions

What is Fluoguide AS's market cap?

Fluoguide AS's market capitalization is SEK 549.34M.